PH11810A - 1,3,7-trisubstituted xanthine peripheral vasodilators - Google Patents

1,3,7-trisubstituted xanthine peripheral vasodilators

Info

Publication number
PH11810A
PH11810A PH17894A PH17894A PH11810A PH 11810 A PH11810 A PH 11810A PH 17894 A PH17894 A PH 17894A PH 17894 A PH17894 A PH 17894A PH 11810 A PH11810 A PH 11810A
Authority
PH
Philippines
Prior art keywords
peripheral vasodilators
trisubstituted xanthine
trisubstituted
xanthine
vasodilators
Prior art date
Application number
PH17894A
Other languages
English (en)
Inventor
W Konz
R Reichl
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of PH11810A publication Critical patent/PH11810A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH17894A 1974-12-21 1975-12-19 1,3,7-trisubstituted xanthine peripheral vasodilators PH11810A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (1)

Publication Number Publication Date
PH11810A true PH11810A (en) 1978-07-10

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
PH17894A PH11810A (en) 1974-12-21 1975-12-19 1,3,7-trisubstituted xanthine peripheral vasodilators

Country Status (31)

Country Link
US (1) US3998953A (es)
JP (1) JPS5188995A (es)
AT (1) AT341540B (es)
AU (1) AU501889B2 (es)
BE (1) BE836898A (es)
BG (1) BG25518A3 (es)
CA (1) CA1036159A (es)
CH (1) CH628346A5 (es)
CS (1) CS191289B2 (es)
DD (1) DD124984A5 (es)
DE (1) DE2460929A1 (es)
DK (1) DK137677C (es)
ES (2) ES443738A1 (es)
FI (1) FI62089C (es)
FR (1) FR2294706A1 (es)
GB (1) GB1517710A (es)
GR (1) GR59204B (es)
HU (1) HU174673B (es)
IE (1) IE43208B1 (es)
IL (1) IL48697A (es)
LU (1) LU73972A1 (es)
NL (1) NL7514837A (es)
NO (1) NO144928C (es)
NZ (1) NZ179599A (es)
PH (1) PH11810A (es)
PL (1) PL99165B1 (es)
RO (1) RO68381A (es)
SE (1) SE420493B (es)
SU (1) SU603340A3 (es)
YU (1) YU39004B (es)
ZA (1) ZA757865B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (en) * 1997-12-17 1999-06-24 University Of South Florida Adenosine receptor antagonists with improved bioactivity
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (es) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (es) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
NO144928B (no) 1981-08-31
FI62089B (fi) 1982-07-30
FI62089C (fi) 1982-11-10
JPS5188995A (es) 1976-08-04
IE43208B1 (en) 1981-01-14
ATA904575A (de) 1977-06-15
IL48697A0 (en) 1976-02-29
NO754317L (es) 1976-06-22
RO68381A (ro) 1982-02-26
YU39004B (en) 1983-12-31
NZ179599A (en) 1978-03-06
YU323475A (en) 1982-08-31
DK137677C (da) 1978-09-25
ZA757865B (en) 1977-08-31
FI753543A (es) 1976-06-22
FR2294706B1 (es) 1978-12-01
NO144928C (no) 1981-12-09
FR2294706A1 (fr) 1976-07-16
AU8754775A (en) 1977-06-23
SU603340A3 (ru) 1978-04-15
GR59204B (en) 1977-11-26
CA1036159A (en) 1978-08-08
IE43208L (en) 1976-06-21
GB1517710A (en) 1978-07-12
IL48697A (en) 1979-07-25
ES443738A1 (es) 1977-04-16
BG25518A3 (en) 1978-10-10
NL7514837A (nl) 1976-06-23
DK137677B (da) 1978-04-17
DD124984A5 (es) 1977-03-23
BE836898A (fr) 1976-06-21
HU174673B (hu) 1980-03-28
AU501889B2 (en) 1979-07-05
US3998953A (en) 1976-12-21
CH628346A5 (de) 1982-02-26
DK571875A (da) 1976-06-22
PL99165B1 (pl) 1978-06-30
SE420493B (sv) 1981-10-12
DE2460929C2 (es) 1987-12-17
CS191289B2 (en) 1979-06-29
LU73972A1 (es) 1977-02-15
ES451457A1 (es) 1977-10-01
AT341540B (de) 1978-02-10
DE2460929A1 (de) 1976-06-24
SE7514477L (sv) 1976-06-22

Similar Documents

Publication Publication Date Title
GB1517016A (en) Reamers
PH11423A (en) 1,1-diaryl-1-oxadiazol-alkylamines
AU8374575A (en) Peptidecylopropylamides having lh-rh/fsh-activity
JPS5134181A (en) 66 mechiru 3 44 jihidoro 1 233 okisachiajin 44 on 2 22 jiokishidokanmiryonoseiho
CA1032815A (en) Caffeine antagonism
PH11810A (en) 1,3,7-trisubstituted xanthine peripheral vasodilators
JPS5134182A (en) 66 mechiru 3 44 jihidoro 1 2 33 okisachiajin 44 on 2 22 jiokishidookariumunoseizohoho
JPS5134183A (en) 66 mechiru 3 44 jihidoro 1 2 33 okisachiajin 44 on 2 22 jiokishidonoseizohoho
JPS5126851A (en) Toransu 44 aminomechirushikurohekisakarubonsan no seizoho
ATA392274A (de) Einrichtung zum antrieb einer durchbiegungsausgleichwalze
IL48002A0 (en) 5-cyanoalkyl-1,3,4-thiadiazole-2-ylureas
GB1507022A (en) Screwdrivers
ZA756191B (en) 1,4-oxazepines
ZA757303B (en) Xanthine derivatives
GB1503917A (en) Inks
AU8638175A (en) Vehicle
GB1522597A (en) Insert
AU496392B2 (en) Purines
IE41250B1 (en) 2,2-bis-hydroxymethylalkanesulphonates
AU8532575A (en) Caravan
JPS5146324A (en) Sosei horiharogen dofutaroshianinnoseiseiho
JPS5117989A (en) Nairon 6 no bunriho
GB1523915A (en) Honing tools
PH13018A (en) 1,2,4-triazolidin-2-ones
IL47000A0 (en) Imidazopyrimidine derivatives